Ikena Oncology Inc (IKNA): $196.9M in cash, cash equivalents, and m...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	904
Boards Moderated	0
Alias Born	05/13/2016

herbied47

Re: None

Friday, 11/10/2023 12:22:34 PM

Friday, November 10, 2023 12:22:34 PM

$196.9M in cash, cash equivalents, and marketable securities, which it said would support operations well into 2026. $5.40 a share in cash
Market cap 37 million as of now. Price targets still between $8 and $11. Lots of upcoming catalyst Bullish

Bullish

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IKNA News

Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 08:59:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2025 11:02:36 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2025 10:58:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2025 10:04:46 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2025 04:23:39 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/24/2025 09:17:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2025 01:18:39 PM
Ikena Oncology shares climb as Kristin Yarema named CEO of soon-to-merge ImageneBio • IH Market News • 07/23/2025 03:33:25 PM
Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company • GlobeNewswire Inc. • 07/23/2025 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2025 08:20:15 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/18/2025 08:01:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2025 08:40:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2025 08:50:41 PM
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals • GlobeNewswire Inc. • 07/15/2025 08:15:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/11/2025 12:38:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2025 12:34:05 PM
Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals • GlobeNewswire Inc. • 07/11/2025 12:00:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/01/2025 08:18:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 08:15:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/11/2025 09:08:33 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 06/09/2025 11:14:19 AM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 05/30/2025 08:47:59 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 12:00:17 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 05/07/2025 08:16:28 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent IKNA News

More IKNA News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent IKNA News

Go Ad-Free